Tumor specimens after acquisition of resistance to EGFR-TKI treatment were derived from the primary lung lesion in 7 patients, pleural effusion in 8, lymph node metastasis in 2, and pericardial effusion in one. This evidence concerns the gene EGFR and Pleural effusion.